Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
25,669,673
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
13,012,529
-
Shares change
-
+13,012,529
-
Total reported value, excl. options
-
$338,184,018
-
Value change
-
+$338,184,018
-
Number of buys
-
54
-
Price
-
$26.18
Institutional Holders of Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML) as of Q4 2023
As of 31 Dec 2023 Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML) had 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,012,529 shares of stock of the company.
Largest 10 holders included Deep Track Capital, LP, Blue Owl Capital Holdings LP, TCG Crossover Management, LLC, QVT Financial LP, BRAIDWELL LP, Avoro Capital Advisors LLC, VANGUARD GROUP INC, GREAT POINT PARTNERS LLC, Qiming U.S. Ventures Management, LLC, and Vivo Capital, LLC.
This table shows 54 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.